| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials
|
Silbert, Sara K.
|
|
|
7 |
18 |
p. 5566-5578
|
article
|
| 2 |
Addressing fertility in adolescent boys with sickle cell disease: emerging clinical and ethical dilemmas
|
Nahata, Leena
|
|
|
7 |
18 |
p. 5351-5353
|
article
|
| 3 |
A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America
|
Rangel-Patiño, Juan
|
|
|
7 |
18 |
p. 5202-5209
|
article
|
| 4 |
An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy
|
Farooq, Faheem
|
|
|
7 |
18 |
p. 5480-5484
|
article
|
| 5 |
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
|
Tamari, Roni
|
|
|
7 |
18 |
p. 5225-5233
|
article
|
| 6 |
A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy
|
Kleman, Ariel
|
|
|
7 |
18 |
p. 5549-5553
|
article
|
| 7 |
Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis
|
Meejun, Tanaporn
|
|
|
7 |
18 |
p. 5624-5636
|
article
|
| 8 |
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
|
Rodriguez-Zabala, Maria
|
|
|
7 |
18 |
p. 5382-5395
|
article
|
| 9 |
Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study
|
Moore, John
|
|
|
7 |
18 |
p. 5554-5565
|
article
|
| 10 |
EASIX-1year and late mortality after allogeneic stem cell transplantation
|
Kordelas, Lambros
|
|
|
7 |
18 |
p. 5374-5381
|
article
|
| 11 |
Editorial Board
|
|
|
|
7 |
18 |
p. i
|
article
|
| 12 |
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials
|
Shimony, Shai
|
|
|
7 |
18 |
p. 5234-5245
|
article
|
| 13 |
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients
|
Schuelke, Matthew R.
|
|
|
7 |
18 |
p. 5603-5607
|
article
|
| 14 |
Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens
|
Seetharam, Sumanth Mosale
|
|
|
7 |
18 |
p. 5433-5445
|
article
|
| 15 |
ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice
|
Bloom, Mackenzie
|
|
|
7 |
18 |
p. 5608-5623
|
article
|
| 16 |
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years
|
Shimony, Shai
|
|
|
7 |
18 |
p. 5354-5358
|
article
|
| 17 |
Front Matter
|
|
|
|
7 |
18 |
p. ii
|
article
|
| 18 |
Haplo ever after: haplo PTCy for children
|
Talano, Julie-An
|
|
|
7 |
18 |
p. 5637-5638
|
article
|
| 19 |
Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor
|
Crees, Zachary D.
|
|
|
7 |
18 |
p. 5210-5214
|
article
|
| 20 |
Hertz L, Flormann D, Birnbaumer L, et al. Evidence of in vivo exogen protein uptake by red blood cells: a putative therapeutic concept. Blood Adv. 2023;7(6):1033-1039.
|
|
|
|
7 |
18 |
p. 5315
|
article
|
| 21 |
Higher rate of progression in HIV– than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease
|
Rasmussen, Camille
|
|
|
7 |
18 |
p. 5663-5669
|
article
|
| 22 |
Histidine-rich glycoprotein: antithrombosis without bleeding
|
Schmaier, Alvin H.
|
|
|
7 |
18 |
p. 5649-5650
|
article
|
| 23 |
Histidine-rich glycoprotein attenuates catheter thrombosis
|
Malik, Rida A.
|
|
|
7 |
18 |
p. 5651-5660
|
article
|
| 24 |
Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
|
Noviello, Maddalena
|
|
|
7 |
18 |
p. 5446-5457
|
article
|
| 25 |
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma
|
Scordo, Michael
|
|
|
7 |
18 |
p. 5579-5585
|
article
|
| 26 |
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study
|
Moreno, Carol
|
|
|
7 |
18 |
p. 5294-5303
|
article
|
| 27 |
Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis
|
Ollila, Thomas A.
|
|
|
7 |
18 |
p. 5470-5479
|
article
|
| 28 |
Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS
|
Stengel, Anna
|
|
|
7 |
18 |
p. 5540-5548
|
article
|
| 29 |
Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation
|
Kim, Alexander B.
|
|
|
7 |
18 |
p. 5396-5408
|
article
|
| 30 |
In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice
|
Li, Bin E.
|
|
|
7 |
18 |
p. 5281-5293
|
article
|
| 31 |
It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma
|
Choa, Ruth
|
|
|
7 |
18 |
p. 5510-5523
|
article
|
| 32 |
Lisi V, Blanchard È, Vladovsky M, et al. Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia. Blood Adv. 2022;6(17):5160-5164.
|
|
|
|
7 |
18 |
p. 5314
|
article
|
| 33 |
Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis
|
Gupta, Vikas
|
|
|
7 |
18 |
p. 5421-5432
|
article
|
| 34 |
Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces HSPCs in mice
|
Nagai, Koki
|
|
|
7 |
18 |
p. 5409-5420
|
article
|
| 35 |
Mesenchymal stromal cells ameliorate chronic GVHD by boosting thymic regeneration in a CCR9-dependent manner in mice
|
Zhang, Xin
|
|
|
7 |
18 |
p. 5359-5373
|
article
|
| 36 |
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303
|
Russler-Germain, David A.
|
|
|
7 |
18 |
p. 5524-5539
|
article
|
| 37 |
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up
|
Zinzani, Pier Luigi
|
|
|
7 |
18 |
p. 5272-5280
|
article
|
| 38 |
Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant
|
Solomon, Scott R.
|
|
|
7 |
18 |
p. 5215-5224
|
article
|
| 39 |
Plasmodium falciparum infection of human erythroblasts induces transcriptional changes associated with dyserythropoiesis
|
Feldman, Tamar P.
|
|
|
7 |
18 |
p. 5496-5509
|
article
|
| 40 |
Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism
|
Ward, Joey
|
|
|
7 |
18 |
p. 5341-5350
|
article
|
| 41 |
Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
|
Lakhotia, Rahul
|
|
|
7 |
18 |
p. 5320-5324
|
article
|
| 42 |
Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias
|
Fierro-Pineda, Juan C.
|
|
|
7 |
18 |
p. 5639-5648
|
article
|
| 43 |
Real-world results of CAR T-cell therapy for large B-cell lymphoma with CNS involvement: a GLA/DRST study
|
Ayuk, Francis
|
|
|
7 |
18 |
p. 5316-5319
|
article
|
| 44 |
Remission after rituximab for HHV8+ MCD: what next?
|
Ramaswami, Ramya
|
|
|
7 |
18 |
p. 5661-5662
|
article
|
| 45 |
Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy
|
Little, Jessica S.
|
|
|
7 |
18 |
p. 5485-5495
|
article
|
| 46 |
Single-cell multiomics of human fetal hematopoiesis define a developmental-specific population and a fetal signature
|
Sommarin, Mikael N. E.
|
|
|
7 |
18 |
p. 5325-5340
|
article
|
| 47 |
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
|
Nikkarinen, Anna
|
|
|
7 |
18 |
p. 5304-5313
|
article
|
| 48 |
Sézary syndrome originates from heavily mutated hematopoietic progenitors
|
Harro, Carly M.
|
|
|
7 |
18 |
p. 5586-5602
|
article
|
| 49 |
The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas
|
Salaverria, Itziar
|
|
|
7 |
18 |
p. 5258-5271
|
article
|
| 50 |
Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?
|
Rezende, Suely M.
|
|
|
7 |
18 |
p. 5199-5201
|
article
|
| 51 |
Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia
|
Hisada, Yohei
|
|
|
7 |
18 |
p. 5458-5469
|
article
|
| 52 |
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH
|
Evseev, Dmitry
|
|
|
7 |
18 |
p. 5246-5257
|
article
|
Journal description